Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial
Abdelrahman Ahmed Abdelalim, Ayman Abdelaal Mohamady, Rasha Elsayed, et al.
American Journal of Otolaryngology (2021) Vol. 42, Iss. 2, pp. 102884-102884
Open Access | Times Cited: 134

Showing 1-25 of 134 citing articles:

Drug treatments for covid-19: living systematic review and network meta-analysis
Reed Siemieniuk, Jessica Bartoszko, Dena Zeraatkar, et al.
BMJ (2020), pp. m2980-m2980
Open Access | Times Cited: 800
Systemic corticosteroids for the treatment of COVID-19
Carina Wagner, Mirko Griesel, Agata Mikołajewska, et al.
Cochrane library (2021) Vol. 2021, Iss. 8
Open Access | Times Cited: 203
Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics
Albert Leng, Manuj Shah, Syed A. Ahmad, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 816-816
Open Access | Times Cited: 119
ESCMID rapid guidelines for assessment and management of long COVID
Dana Yelin, Charalampos D. Moschopoulos, Ili Margalit, et al.
Clinical Microbiology and Infection (2022) Vol. 28, Iss. 7, pp. 955-972
Open Access | Times Cited: 113
Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial
Arianna Di Stadio, Luca D’Ascanio, Luigi Angelo Vaira, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 10, pp. 2001-2012
Open Access | Times Cited: 85
Neuropsychiatric aspects of long COVID: A comprehensive review
Takafumi Kubota, Naoto Kuroda, Daichi Sone
Psychiatry and Clinical Neurosciences (2022) Vol. 77, Iss. 2, pp. 84-93
Open Access | Times Cited: 85
Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments
Raziyeh Najafloo, Jila Majidi, Alimohamad Asghari, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 20, pp. 3795-3805
Closed Access | Times Cited: 88
Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review
Elnaz Khani, Sajad Khiali, Samineh Beheshtirouy, et al.
European Journal of Pharmacology (2021) Vol. 912, pp. 174582-174582
Open Access | Times Cited: 59
Preliminary Guidelines for the Clinical Evaluation and Management of Long COVID
Yoonjung Kim, Seong Eun Kim, Tark Kim, et al.
Infection and Chemotherapy (2022) Vol. 54, Iss. 3, pp. 566-566
Open Access | Times Cited: 55
Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence
Carina Wagner, Mirko Griesel, Agata Mikołajewska, et al.
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 51
Management of post-COVID-19 olfactory dysfunction
Tara J. Wu, Alice Yu, Jivianne T. Lee
Current Treatment Options in Allergy (2022) Vol. 9, Iss. 1, pp. 1-18
Open Access | Times Cited: 40
Clinical effectiveness of rehabilitation in ambulatory care for patients with persisting symptoms after COVID-19: a systematic review
Hannelore Dillen, Geertruida E Bekkering, Sofie Gijsbers, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 23
Effect of nasal corticosteroid in the treatment of anosmia due to COVID-19: A randomised double-blind placebo-controlled study
Rasheed Ali Rashid, Atheer Zgair, Raid M. Al-Ani
American Journal of Otolaryngology (2021) Vol. 42, Iss. 5, pp. 103033-103033
Open Access | Times Cited: 51
Pathophysiology and possible treatments for olfactory-gustatory disorders in patients affected by COVID-19
Francisca Idalina Neta, Amélia Carolina Lopes Fernandes, Adson José Martins Vale, et al.
Current Research in Pharmacology and Drug Discovery (2021) Vol. 2, pp. 100035-100035
Open Access | Times Cited: 50
Oral Mucosa, Saliva, and COVID-19 Infection in Oral Health Care
Devi Sewvandini Atukorala Atukorallaya, Ravindra Kumar Ratnayake
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 48
Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
Lisa O’Byrne, Katie E Webster, Samuel MacKeith, et al.
Cochrane library (2021) Vol. 2021, Iss. 8
Open Access | Times Cited: 46
Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study
Sven Saussez, Luigi Angelo Vaira, Carlos M. Chiesa‐Estomba, et al.
Pathogens (2021) Vol. 10, Iss. 6, pp. 698-698
Open Access | Times Cited: 46
Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial
Hossein Kasiri, Nima Rouhani, Ebrahim Salehifar, et al.
International Immunopharmacology (2021) Vol. 98, pp. 107871-107871
Open Access | Times Cited: 45
Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction
Sven Saussez, Shilpee Sharma, Anaïs Thiriard, et al.
European Journal of Neurology (2021) Vol. 28, Iss. 11, pp. 3702-3711
Open Access | Times Cited: 45
Olfactory recovery following infection with COVID-19: A systematic review
Jafar Ali, Andrea Lasso, Risa Shorr, et al.
PLoS ONE (2021) Vol. 16, Iss. 11, pp. e0259321-e0259321
Open Access | Times Cited: 42
Therapeutic Approaches to the Neurologic Manifestations of COVID-19
Edith L. Graham, Igor J. Koralnik, Eric M. Liotta
Neurotherapeutics (2022) Vol. 19, Iss. 5, pp. 1435-1466
Open Access | Times Cited: 33
Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
Lisa O’Byrne, Katie E Webster, Samuel MacKeith, et al.
Cochrane library (2022) Vol. 2022, Iss. 9
Open Access | Times Cited: 33
Efficacy of topical steroids for the treatment of olfactory disorders caused by COVID‐19: A systematic review and meta‐analysis
Do Hyun Kim, Sung Won Kim, Min Ju Kang, et al.
Clinical Otolaryngology (2022) Vol. 47, Iss. 4, pp. 509-515
Open Access | Times Cited: 29
The Efficacy of Olfactory Training as a Treatment for Olfactory Disorders Caused by Coronavirus Disease-2019: A Systematic Review and Meta-Analysis
Se Hwan Hwang, Sung Won Kim, Mohammed Abdullah Basurrah, et al.
American Journal of Rhinology and Allergy (2023) Vol. 37, Iss. 4, pp. 495-501
Closed Access | Times Cited: 18
Long-lasting olfactory dysfunction in COVID-19 patients
Bernhard Prem, David T. Liu, Gerold Besser, et al.
European Archives of Oto-Rhino-Laryngology (2021) Vol. 279, Iss. 7, pp. 3485-3492
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top